PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biostatistics, Beijing KeyTech Statistical Consulting Co., Ltd, Beijing, China.\', \'Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.\', \'Department of Health Statistics, Air Force Military Medical University, Xi\'an, Shaanxi Province, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/21645515.2020.1815489
?:hasPublicationType
?:journal
  • Human vaccines & immunotherapeutics
is ?:pmid of
?:pmid
?:pmid
  • 32991223
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Considerations on the clinical development of COVID-19 vaccine from trial design perspectives.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32991223>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32991223>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all